Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services
New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
Samelisant will be the centerpiece of Suven’s scientific presence
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
The decision was driven by results from the Phase III CAPItello-281 trial,
Cervical cancer remains one of the leading causes of cancer deaths among women in India
Molbio Diagnostics' Truenat HPV-HR Plus becomes the world's first formally validated reduced-valency HPV test, meeting WHO-IARC standards
Subscribe To Our Newsletter & Stay Updated